Evidence map›Paper›PMID 36764940›Full record

ReviewCell and tissue research2023

Vaccines for prion diseases: a realistic goal?

Scott Napper, Hermann M Schatzl

Open access · hybridAbstract readReview
In one paragraph

Review in Cell and tissue research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Insights into the Diagnosis, Treatment, and Management of Prion Diseases.CNS & neurological disorders drug targets · 2026
    Review
  5. Prion shedding is reduced by chronic wasting disease vaccination.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Therapeutic Trajectories in Human Prion Diseases.Sub-cellular biochemistry · 2025
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Scott NapperVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada. scott.napper@usask.ca.ORCID http://orcid.org/0000-0003-1948-4538
Hermann M SchatzlCalgary Prion Research Unit, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
University of Calgary · CAUniversity of Saskatchewan · CA

Funding

Chronic Wasting Disease VaccinesR01AI156037 · NIAID · COLORADO STATE UNIVERSITY · PI MATHIASON, CANDACE K. · 2021 to 2025
$3.5M
NIAID NIH HHS R01 AI156037
6 · The paper itself

Abstract

Prion diseases are fatal infectious neurodegenerative disorders and prototypic conformational diseases, caused by the conformational conversion of the normal cellular prion protein (PrP

Indexed as

DeerEncephalopathy, Bovine SpongiformPrion DiseasesPrionsVaccinesWasting Disease, ChronicAnimalsCattleGoalsGoatsHumansSheepPrionsVaccinesChronic wasting diseaseImmunotherapyPrionVaccineWildlife vaccine

Identifiers

PMID36764940
PMCPMC9918406
OpenAlexW4320032795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.